Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Avillion LLP
Avillion LLP
Activities:
Research & Development
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Finance
Avillion appoints Kathryn J. Gregory as Chief Business Officer
Regulatory
US FDA and EMA accept submission of BOSULIF for CML treatment
Applications seek to expand approved use of BOSULIF into first-line treatment based on positive results from Phase 3 head-to-head trial
Pharmaceutical
Nanobodies could lead to a new generation of biological drugs
Avillion signs clinical co-development agreement with Merck to advance Anti IL-17 A/F Nanobody in psoriasis
Finance
Avillion appoints Mark Weinberg as Chief Medical Officer
Mark Weinberg will be based in Chicago as CMO for co-developer and financier of late-stage pharmaceutical product candidates
Research & Development
Jarrod Longcor joins Avillion as Chief Business Officer
Will take responsibility for negotiating co-development agreements and financial investments
Research & Development
Dr Allison Jeynes-Ellis becomes Chief Executive at Avillion
Founding member of management team and formerly Chief Medical Officer at the company
Subscribe now